Fatty acid synthase (FASN), a fatty acid synthesis enzyme, has increasingly become a potential therapeutic target for many tumors, and elevated FASN expression significantly correlates with tumor promotion and radioresistance [24, 25]. This evidence concerns the gene FASN and neoplasm.